USA / INTERNATIONAL
UMF Corporation announced that its Micrillon yarns have been shown to inactivate human coronavirus and human influenza A H1N1, and also destroy MRSA and E. coli, meaning the product has significant potential for use in healthcare PPE, among other things .
Test results from the award-winning contract research organization Integrated Pharma Services * confirm that UMF's Micrillon sheath and core fiber have significant antiviral properties against the human coronavirus, which causes Covid-19, and human influenza A H1N1 virus in just a few minutes. The Micrillon sheath and core fiber, spun into a yarn and knitted into a material, also show significant antibacterial activity (100% kill) against Staphylococcus aureus (MRSA) and E. coli 0157: H7. These results have significant implications for a wide range of applications, including various types of yarn for woven and knitted fabrics such as towels, privacy curtains, and personal protective equipment (PPE).
"We are thrilled with the results of the Micrillon tests, which definitely show that they inactivate human coronavirus and influenza and destroy MRSA and E. coli," said George Clarke, CEO of UMF Corporation. “The results are evidence of our commitment to researching and developing high-performance products for infection prevention and commercial cleaning and disinfection. There is a significant impact on industries like healthcare – where it can be included in PPE – as well as hospitality and education, which are more focused than ever on infection prevention in the face of the COVID-19 pandemic. We plan to incorporate micrillon microfibre with fissile two-component components into all of our PerfectCLEAN products this year. "
UMF's Micrillon is a rechargeable, broad-spectrum polymer additive that can be incorporated into films, plastics and fibers and charged with chlorine molecules. Micrillon chemistry charges for the life of the product and does not get into the environment.
When bacteria and mold come into contact with a Micrillon surface, they are eliminated. ie viruses are inactivated. UMF introduced the first Micrillon product in 2019, the C-PULL for curtains to protect privacy in healthcare. In this case, Micrillon was integrated into a unique high-performance fiber from Universal Fiber Systems in Tennessee. Additional fibers, including a segmented 50% polyester and 50% polyamide pie, have been developed and are currently being tested. Antiviral effectiveness tests were carried out based on ISO standard 18184: 2019: Determination of the antiviral activity of textile products.
"We performed an antimicrobial efficacy test on Micrillon in our laboratory. I am pleased to announce that the results have shown that it is effective against influenza and coronavirus strains when used after 10, 30 and 120 minutes of exposure exposed, "said Dr. Mina Izadjoo, President and Chief Science Officer of Integrated Pharma Services. "We are preparing a manuscript of the results of the Micrillon antimicrobial studies to be submitted to journals."
Integrated Pharma Services is currently conducting additional testing on new Micrillon fibers, including Micrillon 50% PET / 50% PA bicomponent split hollow core filament that separates into 16 triangular fibers and one 4DG Micrillon fiber.
Dr. Izadjoo added, “Integrated Pharma Services is committed to providing solutions to difficult-to-treat human diseases and we are excited to be part of the UMF Micrillon trials. We are very pleased to be working with UMF and look forward to helping develop novel solutions for current and emerging infectious diseases. "
• Integrated Pharma Services (IPS) is doing a PhD. Scientists and qualified technical personnel to design, perform and report scientific data. IPS recently set up a mask manufacturing facility in Rockville, MD with support from the State of Maryland.
http://www.integratedpharmaservices.com
